Filing Details

Accession Number:
0001213900-20-007845
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-30 09:23:54
Reporting Period:
2020-03-27
Accepted Time:
2020-03-30 09:23:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513525 Adial Pharmaceuticals Inc. ADIL Pharmaceutical Preparations (2834) 800667150
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718364 Jr. W. James Newman 1180 Seminole Trail, Suite 495
Charlottesville VA 22901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-27 5,000 $1.42 15,000 No 4 P Direct
Common Stock Acquisiton 2020-03-27 10,000 $1.34 13,288 No 4 P Indirect Roundtop Limited Partnership, LLP
Common Stock Acquisiton 2020-03-27 4,644 $1.35 14,644 No 4 P Indirect Roth IRA FBO James W Newman, Jr.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect Roundtop Limited Partnership, LLP
No 4 P Indirect Roth IRA FBO James W Newman, Jr.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 41,160 Indirect Newman GST Trust FBO James W. Newman Jr.
Common Stock 150,419 Indirect Virga Ventures, LLC
Common Stock 35,221 Indirect Ivy Cottage Group, LLC
Footnotes
  1. James W. Newman is the general partner of Roundtop Limited Partnership, LLP.
  2. James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr.
  3. James W. Newman is the sole member of Virga Ventures, LLC.
  4. James W. Newman is the general partner of Ivy Cottage Group, LLC.
  5. James W. Newman is the beneficiary of this Roth IRA.